Amaurosis fugax: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 19: Line 19:


{{SK}} Transient monocular blindness
{{SK}} Transient monocular blindness
==[[Amaurosis fugax overview|Overview]]==
==[[Amaurosis fugax historical perspective|Historical Perspective]]==
==[[Amaurosis fugax pathophysiology|Pathophysiology]]==
==[[Amaurosis fugax causes|Causes]]==
==[[Amaurosis fugax differential diagnosis|Differentiating Amaurosis fugax from other Diseases]]==
==[[Amaurosis fugax epidemiology and demographics|Epidemiology and Demographics]]==
==[[Amaurosis fugax risk factors|Risk Factors]]==
==[[Amaurosis fugax natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==Diagnosis==
[[Amaurosis fugax diagnostic evaluation|Diagnostic Evaluation]] | [[Amaurosis fugax history and symptoms|History and Symptoms]] | [[Amaurosis fugax physical examination|Physical Examination]] | [[Amaurosis fugax laboratory findings|Laboratory Findings]] | [[Amaurosis fugax CT|CT]] | [[Amaurosis fugax MRI|MRI]] | [[Amaurosis fugax echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Amaurosis fugax other imaging findings|Other Imaging Findings]]
==Treatment==
[[Amaurosis fugax medical therapy|Medical Therapy]] | [[Amaurosis fugax surgery|Surgery]] | [[Amaurosis fugax primary prevention|Primary Prevention]] | [[Amaurosis fugax secondary prevention|Secondary Prevention]] | [[Amaurosis fugax cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Amaurosis fugax future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
[[Amaurosis fugax case study one|Case #1]]


==Related Chapters==
==Related Chapters==

Revision as of 15:49, 26 November 2012

Amaurosis fugax
The arteries of the choroid and iris. The greater part of the sclera has been removed.
ICD-10 G45.3
ICD-9 362.34
DiseasesDB 501
MedlinePlus 000784
MeSH D020757

Amaurosis fugax Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Amaurosis fugax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Diagnostic Evaluation

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amaurosis fugax On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amaurosis fugax

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amaurosis fugax

CDC on Amaurosis fugax

Amaurosis fugax in the news

Blogs on Amaurosis fugax

Directions to Hospitals Treating Amaurosis fugax

Risk calculators and risk factors for Amaurosis fugax

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Transient monocular blindness

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Amaurosis fugax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Evaluation | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Related Chapters



Template:Diseases of the nervous system de:Retinaler Arterienverschluss

Template:WikiDoc Sources